Ionis Slumps, Rival Alnylam Soars as GSK Decides Against Trial


Ionis Pharmaceuticals Inc. plunged the most since 2003 after GlaxoSmithKline Plc decided not to test a drug the companies were developing together. Alnylam Pharmaceuticals Inc., which is developing a rival therapy, soared on the news.



from Biotech News